Call us at:

+963949541461

Amiodarone Racha 200

Amiodarone Racha 200

Classification: Drug

Composition: "Each tablet contains: amiodarone hydrochloride 200 mg"

Indications: treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated.

Adverse Reactions: "Thyroid: Common: Hypothyroidism, hyperthyroidism. Cardiovascular Common: Congestive heart failure, cardiac arrhythmias, SA node dysfunction. Gastrointestinal : Very common: Nausea, vomiting. Common: Constipation, anorexia, abdominal pain. Not known: pancreatitis, acute pancreatitis. Dermatologic : Common: Solar dermatitis/photosensitivity. Not known: urticaria, toxic epidermal necrolysis (sometimes fatal), erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, bullous dermatitis, drug rash with eosinophilia and systemic symptoms (DRESS), eczema, pruritus, skin cancer, lupus-like syndrome. Neurologic : Common: Malaise and fatigue, tremor/abnormal involuntary movements, lack of coordination, abnormal gait/ataxia, dizziness, paresthesias, decreased libido, insomnia, headache, sleep disturbances. Not known: pseudotumorcerebri, parkinsonian symptoms (sometimes reversible with discontinuation of therapy), demyelinating polyneuropathy. Ophthalmic: Common: Visual disturbances. Hepatic: Common: Abnormal liver-function tests, nonspecific hepatic disorders. Not known: hepatitis, cholestatic hepatitis, cirrhosis. Respiratory : Common: Pulmonary inflammation or fibrosis. Other : Common: Flushing, abnormal taste and smell, edema, abnormal salivation, coagulation abnormalities. Uncommon: Blue skin discoloration, rash, spontaneous ecchymosis, alopecia, hypotension, and cardiac conduction abnormalities."

Reviews

There are no reviews yet.

Be the first to review “Amiodarone Racha 200”

Your email address will not be published. Required fields are marked *